Powerful Intelligence for Dealmakers
Contract service agreement to build new facility in China
| Companies: |
Takeda Pharmaceutical |
|---|---|
| Announcement date: | Mar 23 2011 |
| Deal value, US$m: | n/d |
Details
| Announcement date: | Mar 23 2011 |
|---|---|
| Industry sectors: |
Bigpharma
Pharmaceutical |
| Technology types: |
Facilities
|
| Deal components: |
Contract service
|
| Geographic focus: |
Asia
»
China
|
Financials
| Deal value, US$m: | n/d |
|---|
Termsheet
Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou.
The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs.
Press Release
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Ups Commitment to China 3/23/2011
March 23, 2011 -- Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou. The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs. The company candidly admits it is playing catch-up in China. “We missed the boat several times in China,” said Yasuchika Hasegawa, President of Takeda, last year. “We are trying to catch the last boat.”
Filing Data
Not available.
Contract
Not available.